Institute of Biomedical Sciences, MacKay Medical College, New Taipei City, Taiwan.
Department of Medicine, Mackay Medical College, New Taipei City, Taiwan.
J Neurosci. 2024 Sep 25;44(39):e0497242024. doi: 10.1523/JNEUROSCI.0497-24.2024.
Nerve injury can induce aberrant changes in the spine; these changes are due to, or at least partly governed by, transcription factors that contribute to the genesis of neuropathic allodynia. Here, we showed that spinal nerve ligation (SNL, a clinical neuropathic allodynia model) increased the expression of the transcription factor Tbx5 in the injured dorsal horn in male Sprague Dawley rats. In contrast, blocking this upregulation alleviated SNL-induced mechanical allodynia, and there was no apparent effect on locomotor function. Moreover, SNL-induced Tbx5 upregulation promoted the recruitment and interaction of GATA4 and Brd4 by enhancing its binding activity to H3K9Ac, which was enriched at the promotor, leading to an increase in TRPV1 transcription and the development of neuropathic allodynia. In addition, nerve injury-induced expression of Fbxo3, which abates Fbxl2-dependent Tbx5 ubiquitination, promoted the subsequent Tbx5-dependent epigenetic modification of TRPV1 expression during SNL-induced neuropathic allodynia. Collectively, our findings indicated that spinal Tbx5-dependent TRPV1 transcription signaling contributes to the development of neuropathic allodynia via Fbxo3-dependent Fbxl2 ubiquitination and degradation. Thus, we propose a potential medical treatment strategy for neuropathic allodynia by targeting Tbx5.
神经损伤可诱导脊柱发生异常变化;这些变化是由转录因子引起的,或者至少部分受其调控,这些转录因子有助于神经病理性痛觉过敏的发生。在这里,我们表明,脊神经结扎(SNL,一种临床神经性痛觉过敏模型)增加了雄性 Sprague Dawley 大鼠损伤背角中转录因子 Tbx5 的表达。相比之下,阻断这种上调可缓解 SNL 诱导的机械性痛觉过敏,而对运动功能没有明显影响。此外,SNL 诱导的 Tbx5 上调通过增强其与 H3K9Ac 的结合活性,促进 GATA4 和 Brd4 的募集和相互作用,该结合活性在启动子处富集,导致 TRPV1 转录增加和神经性痛觉过敏的发展。此外,神经损伤诱导的 Fbxo3 表达,可减弱 Fbxl2 依赖性 Tbx5 泛素化,促进了 SNL 诱导的神经性痛觉过敏过程中 Fbxo3 依赖性 Tbx5 依赖性表观遗传修饰 TRPV1 的表达。总之,我们的研究结果表明,脊髓 Tbx5 依赖性 TRPV1 转录信号通过 Fbxo3 依赖性 Fbxl2 泛素化和降解,导致神经性痛觉过敏的发生。因此,我们提出了一种针对 Tbx5 的潜在神经性痛觉过敏治疗策略。